Early research (Phase 1)Study completedNCT04373265
What this trial is testing
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Who this might be right for
Adrenocortical Carcinoma
Corcept Therapeutics 15